BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Drug Development

  Curis Announces FDA Fast Track Designation for Fimepinostat (CUDC-907) Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  Curis, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of fimepinostat in patients with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.

  May 31, 2018

   · 

  3 min read
• Policy

  Sarissa Capital Issues Statement On Ironwood Pharmaceuticals

  Sarissa Capital Management LP today made the following statement regarding Ironwood Pharmaceuticals, Inc.

  May 31, 2018

   · 

  2 min read
• Pharm Country

  Realm Therapeutics to Present at June 2018 Investor Conferences

  Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on developing novel therapeutics in immune-mediated diseases, today announces that the Company will participate in several investor conferences in June.

  May 31, 2018

   · 

  3 min read
• Business

  Concordia International Corp. Provides Corporate Update

  Concordia International Corp. announced a number of corporate developments.

  May 31, 2018

   · 

  9 min read
• Genetown

  AVEO Oncology to Present at the Jefferies 2018 Healthcare Conference

  AVEO Oncology announced that Michael Bailey, president and chief executive officer, will present at the Jefferies 2018 Healthcare Conference.

  May 31, 2018

   · 

  2 min read
• Business

  GTx, Inc. to Participate in the Jefferies 2018 Global Healthcare Conference

  GTx, Inc. announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Jefferies 2018 Global Healthcare Conference.

  May 31, 2018

   · 

  1 min read
• Genetown

  ArQule to Present at the Jefferies 2018 Healthcare Conference on June 7, 2018

  ArQule, Inc. announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at the Jefferies 2018 Healthcare Conference.

  May 31, 2018

   · 

  2 min read
• Business

  Celltrion and Yonsei University Health System Team up to Develop New Drugs for Cerebrovascular Diseases

  Reinforcing the new biopharmaceutical pipeline: Joint development and license-in agreement with Yonsei University Health System

  May 31, 2018

   · 

  3 min read
• Deals

  American Diversified Holdings Corporation Nears Completion of Brazos Biomedical, LLC Acquisition

  ADHC Eliminates $1.2mm in Debt, Reduces Shares Outstanding by 95mm shares and Files Quarter Financials

  May 31, 2018

   · 

  2 min read
• BioMidwest

  BrainScope Initiates Teenage and Young Adult Multi-Site Clinical Study for Concussion Assessment Product

  BrainScope announced today the initiation of a large, multi-site clinical research study enrolling subjects ages 13-25 years who sustained a head injury from a variety of causes, including sports-related head injuries

  May 31, 2018

   · 

  3 min read